Colloidal Silver

* Final gross prices may vary according to local VAT.

Get Access

Abstract

Colloidal silver proteins were marketed as “patent medicines” in the 1880s for treatment of tetanus, rheumatism, and other disorders. In the first part of the 20th century, they were used to treat the common cold and gonorrhea. Marketing of colloidal silver emerged again around 1990 (Fung et al., 1995). In the fall of 2001, reports of bioterrorism attacks using anthrax sent through the U.S. mail prompted the mayor of Howie-in-the-Hills, Florida to officially endorse the use of colloidal silver by townspeople to prevent anthrax (Siegel, 2001).